Translational research in addiction: Toward a framework for the development of novel therapeutics

Biochemical Pharmacology

Volumn 81, Issue 12, 2011, Pages 1388-1407

  Paterson, Neil E ^a  

^a PSYCHOGENICS INC   (United States)

Author keywords

Dependence; Drug development; Extended access self administration; Substance use disorder; Translational

Indexed keywords

ACAMPROSATE; AMFEBUTAMONE; AORTAL; BENZODIAZEPINE DERIVATIVE; BUPRENORPHINE; COCAINE; DEPADE; DISULFIRAM; FENTANYL; METHADONE; METHAMPHETAMINE; MORPHINE; NALOXONE; NALTREXONE; NICOTINE; PHENCYCLIDINE; TOPIRAMATE; UNCLASSIFIED DRUG; VARENICLINE;

ADDICTION; ALCOHOLISM; CLINICAL FEATURE; COGNITION; COMPULSION; DECISION MAKING; DRUG SELF ADMINISTRATION; DYSPHORIA; HEROIN DEPENDENCE; HUMAN; MEDICAL RESEARCH; MODEL; NONHUMAN; OPIATE ADDICTION; PATIENT COMPLIANCE; PRIORITY JOURNAL; RELAPSE; REVIEW; SUBSTANCE ABUSE; TOBACCO DEPENDENCE; VALIDATION PROCESS; VALIDITY; WITHDRAWAL SYNDROME;

COGNITION; DECISION MAKING; HUMANS; SUBSTANCE WITHDRAWAL SYNDROME; SUBSTANCE-RELATED DISORDERS; TRANSLATIONAL RESEARCH;

EID: 79956197852     PISSN: 00062952     EISSN: 18732968     Source Type: Journal    
DOI: 10.1016/j.bcp.2010.12.017     Document Type: Review

References (287)

1. Centers for Disease Control and Prevention (CDC) State-specific smoking-attributable mortality and years of potential life lost - United States, 2000-2004 MMWR Morb Mortal Wkly Rep 58 2009 29 33
2. Centers for Disease Control and Prevention (CDC) Vital signs: binge drinking among high school students and adults - United States, 2009 MMWR Morb Mortal Wkly Rep 59 2010 1274 1279
3. Office of National Drug Control Policy The economic costs of drug abuse in the United States: 1992-2002 2004 Office of National Drug Control Policy Washington, DC
4. S. Darke Mortality amongst illicit drug users 2007 Cambridge University Press UK p. 81-95
5. C.P. Adams, and V.V. Brantner Spending on new drug development Health Econ 19 2010 130 141
6. D.E. Jorenby, J.T. Hays, N.A. Rigotti, S. Azoulay, E.J. Watsky, and K.E. Williams Efficacy of varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs placebo or sustained-release bupropion for smoking cessation: a randomized controlled trial J Am Med Assoc 296 2006 56 63
7. D. Gonzales, S.I. Rennard, M. Nides, C. Oncken, S. Azoulay, and C.B. Billing Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, vs sustained-release bupropion and placebo for smoking cessation: a randomized controlled trial J Am Med Assoc 296 2006 47 55
8. G.F. Koob, G. Kenneth Lloyd, and B.J. Mason Development of pharmacotherapies for drug addiction: a Rosetta stone approach Nat Rev Drug Discov 8 2009 500 515
9. American Psychiatric Association Diagnostic and statistical manual of mental disorders 4th ed. 1994 American Psychiatric Association Washington, DC
10. World Health Organization ICD-10 Chapter V: Mental and behavioural disorders 1993
11. G.F. Koob, and N.D. Volkow Neurocircuitry of addiction Neuropsychopharmacology 35 2010 217 238
12. B.J. Everitt, and T.W. Robbins Neural systems of reinforcement for drug addiction: from actions to habits to compulsion Nat Neurosci 8 2005 1481 1489 (Pubitemid 41573659)
13. G.F. Koob, and M. Le Moal Neurobiological mechanisms for opponent motivational processes in addiction Philos Trans R Soc Lond B Biol Sci 363 2008 3113 3123
14. O. George, and G.F. Koob Individual differences in prefrontal cortex function and the transition from drug use to drug dependence Neurosci Biobehav Rev 35 2010 232 247
15. S.B. Ostlund, and B.W. Balleine On habits and addiction: an associative analysis of compulsive drug seeking Drug Discov Today Dis Models 5 2008 235 245
16. R.L. Solomon, and J.D. Corbit An opponent-process theory of motivation. I. Temporal dynamics of affect Psychol Rev 81 1974 119 145
17. A. Wikler Dynamics of drug dependence. Implications of a conditioning theory for research and treatment Arch Gen Psychiatry 28 1973 611 616
18. S.H. Ahmed, and G.F. Koob Transition from moderate to excessive drug intake: change in hedonic set point Science 282 1998 298 300 (Pubitemid 28487203)
19. G.F. Koob, and M. Le Moal Drug addiction, dysregulation of reward, and allostasis Neuropsychopharmacology 24 2001 97 129
20. T.E. Robinson, and K.C. Berridge The incentive sensitization theory of addiction: some current issues Philos Trans R Soc Lond B Biol Sci 363 2008 3137 3146
21. D.H. Epstein, K.L. Preston, J. Stewart, and Y. Shaham Toward a model of drug relapse: an assessment of the validity of the reinstatement procedure Psychopharmacology 189 2006 1 16 (Pubitemid 44607255)
22. S.M. Groman, A.S. James, and J.D. Jentsch Poor response inhibition: at the nexus between substance abuse and attention deficit/hyperactivity disorder Neurosci Biobehav Rev 33 2009 690 698
23. T. Carnwath Prescribing heroin Am J Addict 14 2005 311 318 (Pubitemid 41318269)
24. A. Uchtenhagen Heroin-assisted treatment in Switzerland: a case study in policy change Addiction 105 2010 29 37
25. D. Falk, X.Q. Wang, L. Liu, J. Fertig, M. Mattson, and M. Ryan Percentage of subjects with no heavy drinking days: evaluation as an efficacy endpoint for alcohol clinical trials Alcohol Clin Exp Res 2010 10.1111/j.1530-0277.2010. 01290.x [Epub 23 July 2010]
26. M. Danhof, G. Alvan, S.G. Dahl, J. Kuhlmann, and G. Paintaud Mechanism-based pharmacokinetic-pharmacodynamic modeling - a new classification of biomarkers Pharm Res 22 2005 1432 1437 (Pubitemid 41215882)
27. S.R. Goldberg, J.H. Woods, and C.R. Schuster Morphine: conditioned increases in self-administration in rhesus monkeys Science 166 1969 1306 1307
28. T. Thompson, and R. Pickens Stimulant self-administration by animals: some comparisons with opiate self-administration Fed Proc 29 1970 6 12
29. V.J. DeNoble, and P.C. Mele Intravenous nicotine self-administration in rats: effects of mecamylamine, hexamethonium and naloxone Psychopharmacology 184 2006 266 272 (Pubitemid 43255842)
30. J.L. Falk, H.H. Samson, and G. Winger Behavioral maintenance of high concentrations of blood ethanol and physical dependence in the rat Science 177 1972 811 813
31. N.J. Grahame, T.J. Phillips, S. Burkhart-Kasch, and C.L. Cunningham Intravenous cocaine self-administration in the C57BL/6J mouse Pharmacol Biochem Behav 51 1995 827 834
32. J.D. Valentine, J.S. Hokanson, S.G. Matta, and B.M. Sharp Self-administration in rats allowed unlimited access to nicotine Psychopharmacology 133 1997 300 304 (Pubitemid 27445664)
33. N.H. Mutschler, and K.A. Miczek Withdrawal from i.v. cocaine "binges" in rats: ultrasonic distress calls and startle Psychopharmacology 135 1998 161 168 (Pubitemid 28055499)
34. S.H. Ahmed, J.R. Walker, and G.F. Koob Persistent increase in the motivation to take heroin in rats with a history of drug escalation Neuropsychopharmacology 22 2000 413 421 (Pubitemid 30105769)
35. O. Kitamura, S. Wee, S.E. Specio, G.F. Koob, and L. Pulvirenti Escalation of methamphetamine self-administration in rats: a dose-effect function Psychopharmacology 186 2006 48 53 (Pubitemid 43668310)
36. N.E. Paterson Behavioural and pharmacological mechanisms of bupropion's anti-smoking effects: recent preclinical and clinical insights Eur J Pharmacol 603 2009 1 11
37. R.F. Mucha, D. van der Kooy, M. O'Shaughnessy, and P. Bucenieks Drug reinforcement studied by the use of place conditioning in rat Brain Res 243 1982 91 105 (Pubitemid 12082367)
38. D. Gilbert, and S.J. Cooper beta-Phenylethylamine-, d-amphetamine-and l-amphetamine-induced place preference conditioning in rats Eur J Pharmacol 95 1983 311 314 (Pubitemid 14221373)
39. L.D. Reid, G.A. Hunter, C.M. Beaman, and C.L. Hubbell Toward understanding ethanol's capacity to be reinforcing: a conditioned place preference following injections of ethanol Pharmacol Biochem Behav 22 1985 483 487 (Pubitemid 15140961)
40. P.J. Fudala, K.W. Teoh, and E.T. Iwamoto Pharmacologic characterization of nicotine-induced conditioned place preference Pharmacol Biochem Behav 22 1985 237 241 (Pubitemid 15132106)
41. A.G. Phillips, and F.G. LePiane Reinforcing effects of morphine microinjection into the ventral tegmental area Pharmacol Biochem Behav 12 1980 965 968 (Pubitemid 10039686)
42. S. Mobini, T.J. Chiang, M.Y. Ho, C.M. Bradshaw, and E. Szabadi Comparison of the effects of clozapine, haloperidol, chlorpromazine and d-amphetamine on performance on a time-constrained progressive ratio schedule and on locomotor behaviour in the rat Psychopharmacology 152 2000 47 54
43. M.I. Palmatier, X. Liu, A.R. Caggiula, E.C. Donny, and A.F. Sved The role of nicotinic acetylcholine receptors in the primary reinforcing and reinforcement-enhancing effects of nicotine Neuropsychopharmacology 32 2007 1098 1108 (Pubitemid 46631984)
44. M.E. Olds, and E.F. Domino Comparison of muscarinic and nicotinic cholinergic agonists on self-stimulation behavior J Pharmacol Exp Ther 166 1969 189 204
45. C. Kornetsky, and R.U. Esposito Euphorigenic drugs: effects on the reward pathways of the brain Fed Proc 38 1979 2473 2476 (Pubitemid 10249276)
46. P. Bauco, and R.A. Wise Potentiation of lateral hypothalamic and midline mesencephalic brain stimulation reinforcement by nicotine: examination of repeated treatment J Pharmacol Exp Ther 271 1994 294 301 (Pubitemid 24333142)
47. P.J. Kenny, I. Polis, G.F. Koob, and A. Markou Low dose cocaine self-administration transiently increases but high dose cocaine persistently decreases brain reward function in rats Eur J Neurosci 17 2003 191 195 (Pubitemid 36098891)
48. P.J. Kenny, and A. Markou Nicotine self-administration acutely activates brain reward systems and induces a long-lasting increase in reward sensitivity Neuropsychopharmacology 31 2006 1203 1211 (Pubitemid 43971837)
49. J.R. Taylor, and T.W. Robbins 6-Hydroxydopamine lesions of the nucleus accumbens, but not of the caudate nucleus, attenuate enhanced responding with reward-related stimuli produced by intra-accumbens d-amphetamine Psychopharmacology 90 1986 390 397 (Pubitemid 16022477)
50. P. Olausson, J.D. Jentsch, and J.R. Taylor Nicotine enhances responding with conditioned reinforcement Psychopharmacology 171 2004 173 178 (Pubitemid 38134654)
51. N. Chaudhri, A.R. Caggiula, E.C. Donny, S. Booth, M. Gharib, and L. Craven Operant responding for conditioned and unconditioned reinforcers in rats is differentially enhanced by the primary reinforcing and reinforcement- enhancing effects of nicotine Psychopharmacology 189 2006 27 36 (Pubitemid 44607257)
52. S.L. Walsh, E.C. Donny, P.A. Nuzzo, A. Umbricht, and G.E. Bigelow Cocaine abuse versus cocaine dependence: cocaine self-administration and pharmacodynamic response in the human laboratory Drug Alcohol Depend 106 2010 28 37
53. M. Sofuoglu, S. Yoo, K.P. Hill, and M. Mooney Self-administration of intravenous nicotine in male and female cigarette smokers Neuropsychopharmacology 33 2008 715 720 (Pubitemid 351252695)
54. R. De La Garza 2nd, T. Zorick, E.D. London, and T.F. Newton Evaluation of modafinil effects on cardiovascular, subjective, and reinforcing effects of methamphetamine in methamphetamine-dependent volunteers Drug Alcohol Depend 106 2010 173 180
55. D.M. Harvey, S. Yasar, S.J. Heishman, L.V. Panlilio, J.E. Henningfield, and S.R. Goldberg Nicotine serves as an effective reinforcer of intravenous drug-taking behavior in human cigarette smokers Psychopharmacology 175 2004 134 142 (Pubitemid 39222342)
56. U.S. Zimmermann, I. Mick, V. Vitvitskyi, M.H. Plawecki, K.F. Mann, and S. O'Connor Development and pilot validation of computer-assisted self-infusion of ethanol (CASE): a new method to study alcohol self-administration in humans Alcohol Clin Exp Res 32 2008 1321 1328
57. S.D. Comer, E.D. Collins, and M.W. Fischman Buprenorphine sublingual tablets: effects on IV heroin self-administration by humans Psychopharmacology 154 2001 28 37 (Pubitemid 32186512)
58. O. Pogarell, W. Koch, G. Pöpperl, K. Tatsch, F. Jakob, and P. Zwanzger Striatal dopamine release after prefrontal repetitive transcranial magnetic stimulation in major depression: preliminary results of a dynamic [123I] IBZM SPECT study J Psychiatr Res 40 2006 307 314 (Pubitemid 43668986)
59. H. Rollema, L.K. Chambers, J.W. Coe, J. Glowa, R.S. Hurst, and L.A. Lebel Pharmacological profile of the alpha4beta2 nicotinic acetylcholine receptor partial agonist varenicline, an effective smoking cessation aid Neuropharmacology 52 2007 985 994 (Pubitemid 46227486)
60. E.C. O'Connor, D. Parker, H. Rollema, and A.N. Mead The alpha4beta2 nicotinic acetylcholine-receptor partial agonist varenicline inhibits both nicotine self-administration following repeated dosing and reinstatement of nicotine seeking in rats Psychopharmacology 208 2010 365 376
61. K. Spiller, Z.X. Xi, X. Li, C.R. Ashby Jr., P.M. Callahan, and A. Tehim Varenicline attenuates nicotine-enhanced brain-stimulation reward by activation of alpha4beta2 nicotinic receptors in rats Neuropharmacology 57 2009 60 66
62. R. West, C.L. Baker, J.C. Cappelleri, and A.G. Bushmakin Effect of varenicline and bupropion SR on craving, nicotine withdrawal symptoms, and rewarding effects of smoking during a quit attempt Psychopharmacology 197 2008 371 377
63. M. Sofuoglu, A.I. Herman, M. Mooney, and A.J. Waters Varenicline attenuates some of the subjective and physiological effects of intravenous nicotine in humans Psychopharmacology 207 2009 153 162
64. K. Cahill, L. Stead, and T. Lancaster A preliminary benefit-risk assessment of varenicline in smoking cessation Drug Safety 32 2009 119 135
65. J.R. Hughes, L.F. Stead, and T. Lancaster Antidepressants for smoking cessation Cochrane Database Syst Rev 1 2007 CD000031
66. S.A. McKee, E.L. Harrison, S.S. O'Malley, S. Krishnan-Sarin, J. Shi, and J.M. Tetrault Varenicline reduces alcohol self-administration in heavy-drinking smokers Biol Psychiatry 66 2009 185 190
67. P. Steensland, J.A. Simms, J. Holgate, J.K. Richards, and S.E. Bartlett Varenicline, an alpha4beta2 nicotinic acetylcholine receptor partial agonist, selectively decreases ethanol consumption and seeking Proc Natl Acad Sci USA 104 2007 12518 12523 (Pubitemid 47206170)
68. C.M. Knapp, M. Mercado, T.L. Markley, S. Crosby, D.A. Ciraulo, and C. Kornetsky Zonisamide decreases ethanol intake in rats and mice Pharmacol Biochem Behav 87 2007 65 72 (Pubitemid 46855820)
69. G.A. Hargreaves, and I.S. McGregor Topiramate moderately reduces the motivation to consume alcohol and has a marked antidepressant effect in rats Alcohol Clin Exp Res 31 2007 1900 1907 (Pubitemid 47609640)
70. F.J. Breslin, B.A. Johnson, and W.J. Lynch Effect of topiramate treatment on ethanol consumption in rats Psychopharmacology 207 2010 529 534
71. B.A. Johnson, N. Ait-Daoud, C.L. Bowden, C.C. DiClemente, J.D. Roache, and K. Lawson Oral topiramate for treatment of alcohol dependence: a randomised controlled trial Lancet 361 2003 1677 1685 (Pubitemid 36577440)
72. B.A. Johnson, N. Rosenthal, J.A. Capece, F. Wiegand, L. Mao, and K. Beyers Topiramate for treating alcohol dependence: a randomized controlled trial J Am Med Assoc 298 2007 1641 1651 (Pubitemid 47606653)
73. K.M. Kantak, S.L. Collins, E.G. Lipman, J. Bond, K. Giovanoni, and B.S. Fox Evaluation of anti-cocaine antibodies and a cocaine vaccine in a rat self-administration model Psychopharmacology 148 2000 251 262 (Pubitemid 30136732)
74. B.A. Martell, F.M. Orson, J. Poling, E. Mitchell, R.D. Rossen, and T. Gardner Cocaine vaccine for the treatment of cocaine dependence in methadone-maintained patients: a randomized, double-blind, placebo-controlled efficacy trial Arch Gen Psychiatry 66 2009 1116 1123
75. M. Haney, E.W. Gunderson, H. Jiang, E.D. Collins, and R.W. Foltin Cocaine-specific antibodies blunt the subjective effects of smoked cocaine in humans Biol Psychiatry 67 2010 59 65
76. P. Lobmaier, M. Gossop, H. Waal, and J. Bramness The pharmacological treatment of opioid addiction - a clinical perspective Eur J Clin Pharmacol 66 2010 537 545
77. N.D. Volkow, J.S. Fowler, and G.J. Wang Role of dopamine in drug reinforcement and addiction in humans: results from imaging studies Behav Pharmacol 13 2002 355 366 (Pubitemid 35178832)
78. S.M. Cox, C. Benkelfat, A. Dagher, J.S. Delaney, F. Durand, and S.A. McKenzie Striatal dopamine responses to intranasal cocaine self-administration in humans Biol Psychiatry 65 2009 846 850
79. R.C. Risinger, B.J. Salmeron, T.J. Ross, S.L. Amen, M. Sanfilipo, and R.G. Hoffmann Neural correlates of high and craving during cocaine self-administration using BOLD fMRI Neuroimage 26 2005 1097 1108 (Pubitemid 40806488)
80. R. Ranaldi, D. Pocock, R. Zereik, and R.A. Wise Dopamine fluctuations in the nucleus accumbens during maintenance, extinction, and reinstatement of intravenous d-amphetamine self-administration J Neurosci 19 1999 4102 4109 (Pubitemid 29222282)
81. H.O. Pettit, and J.B. Justice Jr. Dopamine in the nucleus accumbens during cocaine self-administration as studied by in vivo microdialysis Pharmacol Biochem Behav 34 1989 899 904 (Pubitemid 20036593)
82. R.I. Melendez, Z.A. Rodd-Henricks, E.A. Engleman, T.K. Li, W.J. McBride, and J.M. Murphy Microdialysis of dopamine in the nucleus accumbens of alcohol-preferring (P) rats during anticipation and operant self-administration of ethanol Alcohol Clin Exp Res 26 2002 318 325 (Pubitemid 34225835)
83. R.A. España, E.B. Oleson, J.L. Locke, B.R. Brookshire, D.C. Roberts, and S.R. Jones The hypocretin-orexin system regulates cocaine self-administration via actions on the mesolimbic dopamine system Eur J Neurosci 31 2010 336 348
84. C. Dugast, M.F. Suaud-Chagny, and F. Gonon Continuous in vivo monitoring of evoked dopamine release in the rat nucleus accumbens by amperometry Neuroscience 62 1994 647 654 (Pubitemid 24325643)
85. G. Hernandez, S. Hamdani, H. Rajabi, K. Conover, J. Stewart, and A. Arvanitogiannis Prolonged rewarding stimulation of the rat medial forebrain bundle: neurochemical and behavioral consequences Behav Neurosci 120 2006 888 904
86. Z.B. You, Y.Q. Chen, and R.A. Wise Dopamine and glutamate release in the nucleus accumbens and ventral tegmental area of rat following lateral hypothalamic self-stimulation Neuroscience 107 2001 629 639 (Pubitemid 33097499)
87. A.G. Phillips, C.D. Blaha, and H.C. Fibiger Neurochemical correlates of brain-stimulation reward measured by ex vivo and in vivo analyses Neurosci Biobehav Rev 13 1989 99 104 (Pubitemid 19241923)
88. W.M. Doyon, V. Ramachandra, H.H. Samson, C.L. Czachowski, and R.A. Gonzales Accumbal dopamine concentration during operant self-administration of a sucrose or a novel sucrose with ethanol solution Alcohol 34 2004 261 271 (Pubitemid 40292785)
89. V. Deroche-Gamonet, D. Belin, and P.V. Piazza Evidence for addiction-like behavior in the rat Science 305 2004 1014 1017 (Pubitemid 39071778)
90. L. Cantin, M. Lenoir, E. Augier, N. Vanhille, S. Dubreucq, and F. Serre Cocaine is low on the value ladder of rats: possible evidence for resilience to addiction PLoS One 5 2010 e11592
91. F.C. Colpaert, C.J. Niemegeers, and P.A. Janssen Cocaine cue in rats as it relates to subjective drug effects: a preliminary report Eur J Pharmacol 40 1976 195 199 (Pubitemid 8007553)
92. F.C. Colpaert, C.J. Niemegeers, and P.A. Janssen Discriminative stimulus properties of analgesic drugs: narcotic versus non-narcotic analgesics Arch Int Pharmacodyn Ther 220 1976 329 332
93. C.P. France, L.R. Gerak, D. Flynn, G.D. Winger, F. Medzihradsky, and J.R. Bagley Behavioral effects and receptor binding affinities of fentanyl derivatives in rhesus monkeys J Pharmacol Exp Ther 274 1995 17 28
94. J. Besheer, J.J. Grondin, M.C. Salling, M. Spanos, R.A. Stevenson, and C.W. Hodge Interoceptive effects of alcohol require mGlu5 receptor activity in the nucleus accumbens J Neurosci 29 2009 9582 9591
95. N.E. Paterson, W. Min, A. Hackett, D. Lowe, T. Hanania, and B. Caldarone The high-affinity nAChR partial agonists varenicline and sazetidine-A exhibit reinforcing properties in rats Prog Neuropsychopharmacol Biol Psychiatry 2010 10.1016/j.pnpbp.2010.07.037
96. S.J. Heishman, and J.E. Henningfield Discriminative stimulus effects of d-amphetamine, methylphenidate, and diazepam in humans Psychopharmacology 103 1991 436 442
97. C.E. Johanson, L.H. Lundahl, N. Lockhart, and H. Schubiner Intravenous cocaine discrimination in humans Exp Clin Psychopharmacol 14 2006 99 108 (Pubitemid 43988628)
98. R.J. Sevak, W.W. Stoops, L.R. Hays, and C.R. Rush Discriminative stimulus and subject-rated effects of methamphetamine, d-amphetamine, methylphenidate, and triazolam in methamphetamine-trained humans J Pharmacol Exp Ther 328 2009 1007 1018
99. T. Duka, D.N. Stephens, C. Russell, and R. Tasker Discriminative stimulus properties of low doses of ethanol in humans Psychopharmacology 136 1998 379 389 (Pubitemid 28189668)
100. K.L. Preston, I.A. Liebson, and G.E. Bigelow Discrimination of agonist-antagonist opioids in humans trained on a two-choice saline-hydromorphone discrimination J Pharmacol Exp Ther 261 1992 62 71
101. K.A. Perkins Discriminative stimulus effects of nicotine in humans Handb Exp Pharmacol 192 2009 369 400
102. J.A. Lile, W.W. Stoops, A.R. Vansickel, P.E. Glaser, L.R. Hays, and C.R. Rush Aripiprazole attenuates the discriminative-stimulus and subject-rated effects of d-amphetamine in humans Neuropsychopharmacology 30 2005 2103 2114 (Pubitemid 43093509)
103. S.I. Dworkin, S. Mirkis, and J.E. Smith Response-dependent versus response-independent presentation of cocaine: differences in the lethal effects of the drug Psychopharmacology 117 1995 262 266
104. E.C. Donny, A.R. Caggiula, C. Rose, K.S. Jacobs, M.M. Mielke, and A.F. Sved Differential effects of response-contingent and response-independent nicotine in rats Eur J Pharmacol 402 2000 231 240 (Pubitemid 30665848)
105. H.E. Jones, G.E. Bigelow, and K.L. Preston Assessment of opioid partial agonist activity with a three-choice hydromorphone dose-discrimination procedure J Pharmacol Exp Ther 289 1999 1350 1361 (Pubitemid 29246664)
106. D.M. Platt, J.K. Rowlett, and R.D. Spealman Discriminative stimulus effects of intravenous heroin and its metabolites in rhesus monkeys: opioid and dopaminergic mechanisms J Pharmacol Exp Ther 299 2001 760 767
107. J.W. Smith, A. Mogg, E. Tafi, E. Peacey, I.A. Pullar, and P. Szekeres Ligands selective for alpha4beta2 but not alpha3beta4 or alpha7 nicotinic receptors generalise to the nicotine discriminative stimulus in the rat Psychopharmacology 190 2007 157 170 (Pubitemid 46011176)
108. M.G. LeSage, D. Shelley, J.T. Ross, F.I. Carroll, and W.A. Corrigall Effects of the nicotinic receptor partial agonists varenicline and cytisine on the discriminative stimulus effects of nicotine in rats Pharmacol Biochem Behav 91 2009 461 467
109. S.R. Laviolette, T.O. Alexson, and D. van der Kooy Lesions of the tegmental pedunculopontine nucleus block the rewarding effects and reveal the aversive effects of nicotine in the ventral tegmental area J Neurosci 22 2002 8653 8660 (Pubitemid 35387605)
110. S.R. Laviolette, N.M. Lauzon, S.F. Bishop, N. Sun, and H. Tan Dopamine signaling through D1-like versus D2-like receptors in the nucleus accumbens core versus shell differentially modulates nicotine reward sensitivity J Neurosci 28 2008 8025 8033
111. S.R. Laviolette, and D. van der Kooy The motivational valence of nicotine in the rat ventral tegmental area is switched from rewarding to aversive following blockade of the alpha7-subunit-containing nicotinic acetylcholine receptor Psychopharmacology 166 2003 306 313 (Pubitemid 36384779)
112. C.M. Davis, and A.L. Riley Conditioned taste aversion learning: implications for animal models of drug abuse Ann N Y Acad Sci 1187 2010 247 275
113. P.S. Grigson, R.A. Wheeler, D.S. Wheeler, and S.M. Ballard Chronic morphine treatment exaggerates the suppressive effects of sucrose and cocaine, but not lithium chloride, on saccharin intake in Sprague-Dawley rats Behav Neurosci 115 2001 403 416 (Pubitemid 32378169)
114. P.S. Grigson Conditioned taste aversions and drugs of abuse: a reinterpretation Behav Neurosci 111 1997 129 136 (Pubitemid 27097524)
115. N.E. Paterson, D.J. Balfour, and A. Markou Chronic bupropion differentially alters the reinforcing, reward-enhancing and conditioned motivational properties of nicotine in rats Nicotine Tob Res 10 2008 995 1008 (Pubitemid 351998436)
116. T.H. Hand, G.F. Koob, L. Stinus, and M. Le Moal Aversive properties of opiate receptor blockade: evidence for exclusively central mediation in naive and morphine-dependent rats Brain Res 474 December (2) 1988 364 368
117. G.A. Higgins, P. Nguyen, N. Joharchi, and E.M. Sellers Effects of 5-HT3 receptor antagonists on behavioural measures of naloxone-precipitated opioid withdrawal Psychopharmacology 105 1991 322 328
118. T. Suzuki, Y. Ise, M. Tsuda, J. Maeda, and M. Misawa Mecamylamine- precipitated nicotine-withdrawal aversion in rats Eur J Pharmacol 314 1996 281 284 (Pubitemid 26382429)
119. S.S. Watkins, L. Stinus, G.F. Koob, and A. Markou Reward and somatic changes during precipitated nicotine withdrawal in rats: centrally and peripherally mediated effects J Pharmacol Exp Ther 292 2000 1053 1064 (Pubitemid 30136601)
120. Y. Ise, M. Narita, H. Nagase, and T. Suzuki Modulation of opioidergic system on mecamylamine-precipitated nicotine-withdrawal aversion in rats Psychopharmacology 151 2000 49 54 (Pubitemid 30639839)
121. A.C. Morse, G. Schulteis, F.A. Holloway, and G.F. Koob Conditioned place aversion to the "hangover" phase of acute ethanol administration in the rat Alcohol 22 2000 19 24
122. J.A. Chester, and L.E. Coon Pentylenetetrazol produces a state-dependent conditioned place aversion to alcohol withdrawal in mice Pharmacol Biochem Behav 95 2010 258 265
123. M.A. Bozarth, C.M. Pudiak, and R. KuoLee Effect of chronic nicotine on brain stimulation reward. II. An escalating dose regimen Behav Brain Res 96 1998 189 194 (Pubitemid 28494136)
124. M.P. Epping-Jordan, S.S. Watkins, G.F. Koob, and A. Markou Dramatic decreases in brain reward function during nicotine withdrawal Nature 393 1998 76 79 (Pubitemid 28240257)
125. G.J. Schaefer, and R.P. Michael Morphine withdrawal produces differential effects on the rate of lever-pressing for brain self-stimulation in the hypothalamus and midbrain in rats Pharmacol Biochem Behav 18 1983 571 577 (Pubitemid 13128875)
126. N.J. Leith, and R.J. Barrett Amphetamine and the reward system: evidence for tolerance and post-drug depression Psychopharmacologia 46 1976 19 25
127. N.E. Paterson, C. Myers, and A. Markou Effects of repeated withdrawal from continuous amphetamine administration on brain reward function in rats Psychopharmacology 152 2000 440 446
128. L. Kokkinidis, and B.D. McCarter Postcocaine depression and sensitization of brain-stimulation reward: analysis of reinforcement and performance effects Pharmacol Biochem Behav 36 1990 463 471 (Pubitemid 20223009)
129. G. Schulteis, A. Markou, M. Cole, and G.F. Koob Decreased brain reward produced by ethanol withdrawal Proc Natl Acad Sci USA 92 1995 5880 5884
130. G. Schulteis, and J. Liu Brain reward deficits accompany withdrawal (hangover) from acute ethanol in rats Alcohol 39 2006 21 28 (Pubitemid 44287278)
131. B.A. Baldo, G.F. Koob, and A. Markou Role of adenosine A2 receptors in brain stimulation reward under baseline conditions and during cocaine withdrawal in rats J Neurosci 19 1999 11017 11026 (Pubitemid 30235745)
132. A. Markou, and G.F. Koob Construct validity of a self-stimulation threshold paradigm: effects of reward and performance manipulations Physiol Behav 51 1992 111 119
133. V.F. Gellert, and S.B. Sparber A comparison of the effects of naloxone upon body weight loss and suppression of fixed-ratio operant behavior in morphine-dependent rats J Pharmacol Exp Ther 201 1977 44 54 (Pubitemid 8085995)
134. B.L. Slifer, R.L. Balster, and W.L. Woolverton Behavioral dependence produced by continuous phencyclidine infusion in rhesus monkeys J Pharmacol Exp Ther 230 1984 399 406 (Pubitemid 14061619)
135. M.E. Carroll, and S.T. Lac Cocaine withdrawal produces behavioral disruptions in rats Life Sci 40 1987 2183 2190 (Pubitemid 17082411)
136. M.E. Carroll, S.T. Lac, M. Asencio, and R.M. Keenan Nicotine dependence in rats Life Sci 45 1989 1381 1388 (Pubitemid 19248166)
137. J.M. Arnold, and D.C. Roberts A critique of fixed and progressive ratio schedules used to examine the neural substrates of drug reinforcement Pharmacol Biochem Behav 57 1997 441 447 (Pubitemid 27296755)
138. A.M. Barr, and A.G. Phillips Withdrawal following repeated exposure to d-amphetamine decreases responding for a sucrose solution as measured by a progressive ratio schedule of reinforcement Psychopharmacology 141 1999 99 106 (Pubitemid 29193301)
139. K. Schwabe, and M. Koch Effects of aripiprazole on operant responding for a natural reward after psychostimulant withdrawal in rats Psychopharmacology 191 2007 759 765 (Pubitemid 46355881)
140. D. Zhang, X. Zhou, X. Wang, X. Xiang, H. Chen, and W. Hao Morphine withdrawal decreases responding reinforced by sucrose self-administration in progressive ratio Addict Biol 12 2007 152 157 (Pubitemid 46753652)
141. M.G. LeSage, D. Burroughs, and P.R. Pentel Effects of nicotine withdrawal on performance under a progressive-ratio schedule of sucrose pellet delivery in rats Pharmacol Biochem Behav 83 2006 585 591 (Pubitemid 43817129)
142. M.E. Hoefer, S.J. Voskanian, G.F. Koob, and L. Pulvirenti Effects of terguride, ropinirole, and acetyl-l-carnitine on methamphetamine withdrawal in the rat Pharmacol Biochem Behav 83 2006 403 409
143. R.E. Vann, R.L. Balster, and P.M. Beardsley Dose, duration, and pattern of nicotine administration as determinants of behavioral dependence in rats Psychopharmacology 184 2006 482 493 (Pubitemid 43255865)
144. J. Besheer, and R.A. Bevins Impact of nicotine withdrawal on novelty reward and related behaviors Behav Neurosci 117 2003 327 340 (Pubitemid 36384251)
145. M. Koch The neurobiology of startle Prog Neurobiol 59 1999 107 128 (Pubitemid 29425879)
146. M. Kalinichev, and S.G. Holtzman Changes in urination/defecation, auditory startle response, and startle-induced ultrasonic vocalizations in rats undergoing morphine withdrawal: similarities and differences between acute and chronic dependence J Pharmacol Exp Ther 304 2003 603 609 (Pubitemid 36152335)
147. S. Rassnick, G.F. Koob, and M.A. Geyer Responding to acoustic startle during chronic ethanol intoxication and withdrawal Psychopharmacology 106 1992 351 358
148. D.R. Helton, D.L. Modlin, J.P. Tizzano, and K. Rasmussen Nicotine withdrawal: a behavioral assessment using schedule controlled responding, locomotor activity, and sensorimotor reactivity Psychopharmacology 113 1993 205 210 (Pubitemid 24001993)
149. D.L. Walker, and M. Davis Anxiogenic effects of high illumination levels assessed with the acoustic startle response in rats Biol Psychiatry 42 1997 461 471 (Pubitemid 27394615)
150. J.S. Brown, H.I. Kalish, and I.E. Farber Conditioned fear as revealed by magnitude of startle response to an auditory stimulus J Exp Psychol 41 1951 317 328
151. S. Jonkman, V.B. Risbrough, M.A. Geyer, and A. Markou Spontaneous nicotine withdrawal potentiates the effects of stress in rats Neuropsychopharmacology 33 2008 2131 2138 (Pubitemid 351992083)
152. M. Fendt, and R.F. Mucha Anxiogenic-like effects of opiate withdrawal seen in the fear-potentiated startle test, an interdisciplinary probe for drug-related motivational states Psychopharmacology 155 2001 242 250 (Pubitemid 32477280)
153. P.G. Goode An implanted reservoir of morphine solution for rapid induction of physical dependence in rats Br J Pharmacol 41 1971 558 566
154. D.H. Malin, J.R. Lake, P. Newlin-Maultsby, L.K. Roberts, J.G. Lanier, and V.A. Carter Rodent model of nicotine abstinence syndrome Pharmacol Biochem Behav 43 1992 779 784
155. B.E. Hunter, J.N. Riley, and D.W. Walker Ethanol dependence in the rat: a parametric analysis Pharmacol Biochem Behav 3 1975 619 629
156. K.A. Perkins, A. Grottenthaler, and A.S. Wilson Lack of reinforcement enhancing effects of nicotine in nondependent smokers Psychopharmacology 205 2009 635 645
157. A.M. Leventhal, G.S. Chasson, E. Tapia, E.K. Miller, and J.W. Pettit Measuring hedonic capacity in depression: a psychometric analysis of three anhedonia scales J Clin Psychol 62 2006 1545 1558 (Pubitemid 44862645)
158. P.A. Nakonezny, T.J. Carmody, D.W. Morris, B.T. Kurian, and M.H. Trivedi
159. J.H. Krystal, E. Webb, C. Grillon, N. Cooney, L. Casal, and C.A. Morgan 3rd Evidence of acoustic startle hyperreflexia in recently detoxified early onset male alcoholics: modulation by yohimbine and m-chlorophenylpiperazine (mCPP) Psychopharmacology 131 1997 207 215 (Pubitemid 27283581)
160. S.M. Stine, C.G. Grillon, C.A. Morgan 3rd, T.R. Kosten, D.S. Charney, and J.H. Krystal Methadone patients exhibit increased startle and cortisol response after intravenous yohimbine Psychopharmacology 154 2001 274 281 (Pubitemid 32247188)
161. B.D. Sussner, D.A. Smelson, S. Rodrigues, A. Kline, M. Losonczy, and D. Ziedonis The validity and reliability of a brief measure of cocaine craving Drug Alcohol Depend 83 2006 233 237
162. R. West, M. Ussher, M. Evans, and M. Rashid Assessing DSM-IV nicotine withdrawal symptoms: a comparison and evaluation of five different scales Psychopharmacology 184 2006 619 627 (Pubitemid 43255878)
163. D.H. Zilm, and E.M. Sellers The quantitative assessment of physical dependence on opiates Drug Alcohol Depend 3 1978 419 428 (Pubitemid 9088058)
164. D. Turkington, and D.C. Drummond How should opiate withdrawal be measured? Drug Alcohol Depend 24 1989 151 153 (Pubitemid 19217149)
165. J.F. Cryan, A.W. Bruijnzeel, K.L. Skjei, and A. Markou Bupropion enhances brain reward function and reverses the affective and somatic aspects of nicotine withdrawal in the rat Psychopharmacology 168 2003 347 358 (Pubitemid 36920920)
166. N.E. Paterson, D.J. Balfour, and A. Markou Chronic bupropion attenuated the anhedonic component of nicotine withdrawal in rats via inhibition of dopamine reuptake in the nucleus accumbens shell Eur J Neurosci 25 2007 3099 3108 (Pubitemid 46888800)
167. D.H. Malin, J.R. Lake, T.D. Smith, H.N. Khambati, R.L. Meyers-Paal, and A.L. Montellano Bupropion attenuates nicotine abstinence syndrome in the rat Psychopharmacology 184 2006 494 503 (Pubitemid 43255866)
168. V.C. Wing, and M. Shoaib Examining the clinical efficacy of bupropion and nortriptyline as smoking cessation agents in a rodent model of nicotine withdrawal Psychopharmacology 195 2007 303 313 (Pubitemid 350160266)
169. K. Fagerström, and J. Hughes Varenicline in the treatment of tobacco dependence Neuropsychiatr Dis Treat 4 2008 353 363 (Pubitemid 351711930)
170. J.D. Raybuck, G.S. Portugal, C. Lerman, and T.J. Gould Varenicline ameliorates nicotine withdrawal-induced learning deficits in C57BL/6 mice Behav Neurosci 122 2008 1166 1171
171. S. Shiffman, S.G. Ferguson, C.J. Gwaltney, M.H. Balabanis, and W.G. Shadel Reduction of abstinence-induced withdrawal and craving using high-dose nicotine replacement therapy Psychopharmacology 184 2006 637 644 (Pubitemid 43255880)
172. A.W. Bruijnzeel, C. Marcinkiewcz, S. Isaac, M.M. Booth, D.M. Dennis, and M.S. Gold The effects of buprenorphine on fentanyl withdrawal in rats Psychopharmacology 191 2007 931 941 (Pubitemid 46399139)
173. D.R. Wesson, and D.E. Smith Buprenorphine in the treatment of opiate dependence J Psychoactive Drugs 42 2010 161 175
174. M.J. Kreek Effects of opiates, opioid antagonists and cocaine on the endogenous opioid system: clinical and laboratory studies NIDA Res Monogr 119 1992 44 48
175. R.F. Anton, H.R. Kranzler, J.P. McEvoy, D.H. Moak, and R. Bianca A double-blind comparison of abecarnil and diazepam in the treatment of uncomplicated alcohol withdrawal Psychopharmacology 131 1997 123 129 (Pubitemid 27261599)
176. J.C. Crabbe Antagonism of ethanol withdrawal convulsions in withdrawal seizure prone mice by diazepam and abecarnil Eur J Pharmacol 221 1992 85 90
177. S.E. File, A. Zharkovsky, and P.K. Hitchcott Effects of nitrendipine, chlordiazepoxide, flumazenil and baclofen on the increased anxiety resulting from alcohol withdrawal Prog Neuropsychopharmacol Biol Psychiatry 16 1992 87 93
178. M.E. Jung, C.J. Wallis, M.B. Gatch, and H. Lal Abecarnil and alprazolam reverse anxiety-like behaviors induced by ethanol withdrawal Alcohol 21 2000 161 168 (Pubitemid 30645958)
179. H.R. Kranzler Evaluation and treatment of anxiety symptoms and disorders in alcoholics J Clin Psychiatry 57S7 1996 15 21
180. D.H. Overstreet, D.J. Knapp, S.S. Moy, and G.R. Breese A 5-HT1A agonist and a 5-HT2c antagonist reduce social interaction deficit induced by multiple ethanol withdrawals in rats Psychopharmacology 167 2003 344 352 (Pubitemid 36754235)
181. R. Maldonado, J.A. Micó, O. Valverde, M.C. Saavedra, I. Leonsegui, and J. Gibert-Rahola Influence of different benzodiazepines on the experimental morphine abstinence syndrome Psychopharmacology 105 1991 197 203
182. D.R. Gehlert, A. Cippitelli, A. Thorsell, A.D. Lê, P.A. Hipskind, and C. Hamdouchi 3-(4-Chloro-2-morpholin-4-yl-thiazol-5-yl)-8-(1-ethylpropyl)-2, 6-dimethyl-imidazo[1,2-b]pyridazine: a novel brain-penetrant, orally available corticotropin-releasing factor receptor 1 antagonist with efficacy in animal models of alcoholism J Neurosci 27 2007 2718 2726 (Pubitemid 46393604)
183. O. George, S. Ghozland, M.R. Azar, P. Cottone, E.P. Zorrilla, and L.H. Parsons CRF-CRF1 system activation mediates withdrawal-induced increases in nicotine self-administration in nicotine-dependent rats Proc Natl Acad Sci USA 104 2007 17198 17203 (Pubitemid 350211014)
184. B.E. Hildebrand, G.G. Nomikos, P. Hertel, B. Schilström, and T.H. Svensson Reduced dopamine output in the nucleus accumbens but not in the medial prefrontal cortex in rats displaying a mecamylamine-precipitated nicotine withdrawal syndrome Brain Res 779 1998 214 225 (Pubitemid 28039954)
185. Y. Shaham, L.K. Adamson, S. Grocki, and W.A. Corrigall Reinstatement and spontaneous recovery of nicotine seeking in rats Psychopharmacology 130 1997 396 403 (Pubitemid 27179734)
186. S.H. Ahmed, and G.F. Koob Cocaine- but not food-seeking behavior is reinstated by stress after extinction Psychopharmacology 132 1997 289 295 (Pubitemid 27351430)
187. R. Ciccocioppo, P.P. Sanna, and F. Weiss Cocaine-predictive stimulus induces drug-seeking behavior and neural activation in limbic brain regions after multiple months of abstinence: reversal by D(1) antagonists Proc Natl Acad Sci USA 98 2001 1976 1981 (Pubitemid 32165608)
188. D. Mueller, and J. Stewart Cocaine-induced conditioned place preference: reinstatement by priming injections of cocaine after extinction Behav Brain Res 115 2000 39 47
189. G. Biala, and B. Budzynska Reinstatement of nicotine-conditioned place preference by drug priming: effects of calcium channel antagonists Eur J Pharmacol 537 2006 85 93
190. S.X. Li, Y. Zou, L.J. Liu, P. Wu, and L. Lu Aripiprazole blocks reinstatement but not expression of morphine conditioned place preference in rats Pharmacol Biochem Behav 92 2009 370 375
191. C.P. O'Brien, T. Testa, T.J. O'Brien, J.P. Brady, and B. Wells Conditioned narcotic withdrawal in humans Science 195 1977 1000 1002 (Pubitemid 8081921)
192. S.R. Goldberg, and C.R. Schuster Conditioned suppression by a stimulus associated with nalorphine in morphine-dependent monkeys J Exp Anal Behav 10 1967 235 242
193. H.A. Baldwin, and G.F. Koob Rapid induction of conditioned opiate withdrawal in the rat Neuropsychopharmacology 8 1993 15 21 (Pubitemid 23011154)
194. P.J. Kenny, and A. Markou Conditioned nicotine withdrawal profoundly decreases the activity of brain reward systems J Neurosci 25 2005 6208 6212 (Pubitemid 40923487)
195. R. Sinha, T. Fuse, L.R. Aubin, and S.S. O'Malley Psychological stress, drug-related cues and cocaine craving Psychopharmacology 152 2000 140 148
196. J.H. Jaffe, N.G. Cascella, K.M. Kumor, and M.A. Sherer Cocaine-induced cocaine craving Psychopharmacology 97 1989 59 64 (Pubitemid 19020384)
197. H. Rosenberg Clinical and laboratory assessment of the subjective experience of drug craving Clin Psychol Rev 29 2009 519 534
198. A.R. Childress, P.D. Mozley, W. McElgin, J. Fitzgerald, M. Reivich, and C.P. O'Brien Limbic activation during cue-induced cocaine craving Am J Psychiatry 156 1999 11 18 (Pubitemid 29034874)
199. R. Sinha, and C.S. Li Imaging stress- and cue-induced drug and alcohol craving: association with relapse and clinical implications Drug Alcohol Rev 26 2007 25 31
200. N.D. Volkow, G.J. Wang, F. Telang, J.S. Fowler, J. Logan, and A.R. Childress Cocaine cues and dopamine in dorsal striatum: mechanism of craving in cocaine addiction J Neurosci 26 2006 6583 6588 (Pubitemid 44318339)
201. B.J. Everitt, D. Belin, D. Economidou, Y. Pelloux, J.W. Dalley, and T.W. Robbins Neural mechanisms underlying the vulnerability to develop compulsive drug-seeking habits and addiction Philos Trans R Soc Lond B Biol Sci 363 2008 3125 3135
202. R. Stretch, and G.J. Gerber Drug-induced reinstatement of amphetamine self-administration behaviour in monkeys Can J Psychol 27 1973 168 177
203. H. de Wit, and J. Stewart Drug reinstatement of heroin-reinforced responding in the rat Psychopharmacology 79 1983 29 31 (Pubitemid 13198530)
204. Y. Shaham, D. Rodaros, and J. Stewart Reinstatement of heroin-reinforced behavior following long-term extinction: implications for the treatment of relapse to drug taking Behav Pharmacol 5 1994 360 364 (Pubitemid 24217300)
205. A.D. Lê, C.X. Poulos, S. Harding, J. Watchus, W. Juzytsch, and Y. Shaham Effects of naltrexone and fluoxetine on alcohol self-administration and reinstatement of alcohol seeking induced by priming injections of alcohol and exposure to stress Neuropsychopharmacology 21 1999 435 444 (Pubitemid 29333082)
206. N.E. Paterson, W. Froestl, and A. Markou Repeated administration of the GABAB receptor agonist CGP44532 decreased nicotine self-administration, and acute administration decreased cue-induced reinstatement of nicotine-seeking in rats Neuropsychopharmacology 30 2005 119 128 (Pubitemid 40024406)
207. S.T. Tiffany, and D.J. Drobes Imagery and smoking urges: the manipulation of affective content Addict Behav 15 1990 531 539
208. H.R. Kranzler, and L.O. Bauer Bromocriptine and cocaine cue reactivity in cocaine-dependent patients Br J Addict 87 1992 1537 1548
209. R. Niaura, D.B. Abrams, W.G. Shadel, D.J. Rohsenow, P.M. Monti, and A.D. Sirota Cue exposure treatment for smoking relapse prevention: a controlled clinical trial Addiction 94 1999 685 695 (Pubitemid 29229481)
210. S. Rösner, A. Hackl-Herrwerth, S. Leucht, P. Lehert, S. Vecchi, and M. Soyka Acamprosate for alcohol dependence Cochrane Database Syst Rev 9 2010 CD004332
211. J.C. Garbutt Efficacy and tolerability of naltrexone in the management of alcohol dependence Curr Pharm Des 16 2010 2091 2097
212. D. Bachteler, D. Economidou, W. Danysz, R. Ciccocioppo, and R. Spanagel The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat Neuropsychopharmacology 30 2005 1104 1110 (Pubitemid 40720968)
213. M.S. Cowen, C. Adams, T. Kraehenbuehl, V. Vengeliene, and A.J. Lawrence The acute anti-craving effect of acamprosate in alcohol-preferring rats is associated with modulation of the mesolimbic dopamine system Addict Biol 10 2005 233 242 (Pubitemid 41306326)
214. M. Soyka, and S. Rösner Opioid antagonists for pharmacological treatment of alcohol dependence - a critical review Curr Drug Abuse Rev 1 2008 280 291
215. G. Biala, N. Staniak, and B. Budzynska Effects of varenicline and mecamylamine on the acquisition, expression, and reinstatement of nicotine-conditioned place preference by drug priming in rats Naunyn Schmiedebergs Arch Pharmacol 381 2010 361 370
216. S.G. Ferguson, and S. Shiffman The relevance and treatment of cue-induced cravings in tobacco dependence J Subst Abuse Treat 36 2009 235 243
217. S. Hussain, L. Zawertailo, U. Busto, M. Zack, P. Farvolden, and P. Selby The impact of chronic bupropion on plasma cotinine and on the subjective effects of ad lib smoking: a randomized controlled trial in unmotivated smokers Addict Behav 35 2010 164 167
218. A.L. Brody, M.A. Mandelkern, G. Lee, E. Smith, M. Sadeghi, and S. Saxena Attenuation of cue-induced cigarette craving and anterior cingulate cortex activation in bupropion-treated smokers: a preliminary study Psychiatry Res 130 2004 269 281 (Pubitemid 38595428)
219. A. Weinstein, J. Greif, Z. Yemini, H. Lerman, A. Weizman, and E. Even-Sapir Attenuation of cue-induced smoking urges and brain reward activity in smokers treated successfully with bupropion J Psychopharmacol 24 2010 829 838
220. R.J. Tyacke, A. Lingford-Hughes, L.J. Reed, and D.J. Nutt GABAB receptors in addiction and its treatment Adv Pharmacol 58 2010 373 396
221. S. Vlachou, and A. Markou GABAB receptors in reward processes Adv Pharmacol 58 2010 315 371
222. S.D. Comer, M.A. Sullivan, E. Yu, J.L. Rothenberg, H.D. Kleber, and K. Kampman Injectable, sustained-release naltrexone for the treatment of opioid dependence: a randomized, placebo-controlled trial Arch Gen Psychiatry 63 2006 210 218 (Pubitemid 43213883)
223. E.M. Krupitsky, E.E. Zvartau, D.V. Masalov, M.V. Tsoi, A.M. Burakov, and V.Y. Egorova Naltrexone for heroin dependence treatment in St. Petersburg, Russia J Subst Abuse Treat 26 2004 285 294 (Pubitemid 38759145)
224. Y. Shaham, and J. Stewart Effects of opioid and dopamine receptor antagonists on relapse induced by stress and re-exposure to heroin in rats Psychopharmacology 125 1996 385 391 (Pubitemid 26227912)
225. P. Bäckström, D. Bachteler, S. Koch, P. Hyytiä, and R. Spanagel mGluR5 antagonist MPEP reduces ethanol-seeking and relapse behavior Neuropsychopharmacology 29 2004 921 928 (Pubitemid 38526792)
226. A.Y. Bespalov, O.A. Dravolina, I. Sukhanov, E. Zakharova, E. Blokhina, and E. Zvartau Metabotropic glutamate receptor (mGluR5) antagonist MPEP attenuated cue- and schedule-induced reinstatement of nicotine self-administration behavior in rats Neuropharmacology 49S1 2005 167 178 (Pubitemid 41115903)
227. P.M. Monti, D.J. Rohsenow, K.E. Hutchison, R.M. Swift, T.I. Mueller, and S.M. Colby Naltrexone's effect on cue-elicited craving among alcoholics in treatment Alcohol Clin Exp Res 23 1999 1386 1394 (Pubitemid 29409353)
228. K. Anggadiredja, K. Sakimura, T. Hiranita, and T. Yamamoto Naltrexone attenuates cue- but not drug-induced methamphetamine seeking: a possible mechanism for the dissociation of primary and secondary reward Brain Res 1021 2004 272 276 (Pubitemid 39165805)
229. C. Burattini, S. Burbassi, G. Aicardi, and L. Cervo Effects of naltrexone on cocaine- and sucrose-seeking behaviour in response to associated stimuli in rats Int J Neuropsychopharmacol 11 2008 103 109
230. X. Liu, M.I. Palmatier, A.R. Caggiula, A.F. Sved, E.C. Donny, and M. Gharib Naltrexone attenuation of conditioned but not primary reinforcement of nicotine in rats Psychopharmacology 202 2009 589 598
231. D.P. Holschneider, J. Yang, T.R. Sadler, N.B. Galifianakis, M.H. Bozorgzadeh, and J.R. Bading Changes in regional brain perfusion during functional brain activation: comparison of [(64)Cu]-PTSM with [(14)C]-Iodoantipyrine Brain Res 1234 2008 32 43
232. D. Belin, A.C. Mar, J.W. Dalley, T.W. Robbins, and B.J. Everitt High impulsivity predicts the switch to compulsive cocaine-taking Science 320 2008 1352 1355 (Pubitemid 351929473)
233. J.L. Perry, E.B. Larson, J.P. German, G.J. Madden, and M.E. Carroll Impulsivity (delay discounting) as a predictor of acquisition of IV cocaine self-administration in female rats Psychopharmacology 178 2005 193 201 (Pubitemid 40379214)
234. J.A. Marusich, and M.T. Bardo Differences in impulsivity on a delay-discounting task predict self-administration of a low unit dose of methylphenidate in rats Behav Pharmacol 20 2009 447 454
235. J.W. Dalley, K. Lääne, Y. Pena, D.E. Theobald, B.J. Everitt, and T.W. Robbins Attentional and motivational deficits in rats withdrawn from intravenous self-administration of cocaine or heroin Psychopharmacology 182 2005 579 587 (Pubitemid 41464640)
236. C.A. Winstanley, R.K. Bachtell, D.E. Theobald, S. Laali, T.A. Green, and A. Kumar Increased impulsivity during withdrawal from cocaine self-administration: role for DeltaFosB in the orbitofrontal cortex Cereb Cortex 19 2009 435 444
237. B. Setlow, I.A. Mendez, M.R. Mitchell, and N.W. Simon Effects of chronic administration of drugs of abuse on impulsive choice (delay discounting) in animal models Behav Pharmacol 20 2009 380 389
238. A. Izquierdo, A.M. Belcher, L. Scott, V.A. Cazares, J. Chen, and S.J. O'Dell Reversal-specific learning impairments after a binge regimen of methamphetamine in rats: possible involvement of striatal dopamine Neuropsychopharmacology 35 2010 505 514
239. J.M. Birrell, and V.J. Brown Medial frontal cortex mediates perceptual attentional set shifting in the rat J Neurosci 20 2000 4320 4324 (Pubitemid 30365702)
240. N.F. Idris, P. Repeto, J.C. Neill, and C.H. Large Investigation of the effects of lamotrigine and clozapine in improving reversal-learning impairments induced by acute phencyclidine and d-amphetamine in the rat Psychopharmacology 179 2005 336 348
241. Y.D. Black, F.R. Maclaren, A.V. Naydenov, W.A. Carlezon Jr., M.G. Baxter, and C. Konradi Altered attention and prefrontal cortex gene expression in rats after binge-like exposure to cocaine during adolescence J Neurosci 26 2006 9656 9665 (Pubitemid 44427704)
242. D.C. Gooding, S. Burroughs, and N.N. Boutros Attentional deficits in cocaine-dependent patients: converging behavioral and electrophysiological evidence Psychiatry Res 160 2008 145 154
243. P.A. Woicik, S.J. Moeller, N. Alia-Klein, T. Maloney, T.M. Lukasik, and O. Yeliosof The neuropsychology of cocaine addiction: recent cocaine use masks impairment Neuropsychopharmacology 34 2009 1112 1122
244. G. Ainslie Specious reward: a behavioral theory of impulsiveness and impulse control Psychol Bull 82 1975 463 496
245. J.R. Monterosso, G. Ainslie, J. Xu, X. Cordova, C.P. Domier, and E.D. London Frontoparietal cortical activity of methamphetamine-dependent and comparison subjects performing a delay discounting task Hum Brain Mapp 28 2007 383 393 (Pubitemid 46717363)
246. N.M. Petry Delay discounting of money and alcohol in actively using alcoholics, currently abstinent alcoholics, and controls Psychopharmacology 154 2001 243 250 (Pubitemid 32247185)
247. W.K. Bickel, and L.A. Marsch Toward a behavioral economic understanding of drug dependence: delay discounting processes Addiction 96 2001 73 86 (Pubitemid 32099341)
248. K.N. Kirby, and N.M. Petry Heroin and cocaine abusers have higher discount rates for delayed rewards than alcoholics or non-drug-using controls Addiction 99 2004 461 471 (Pubitemid 38496662)
249. S. Dehaene, and J.P. Changeux The Wisconsin Card Sorting Test: theoretical analysis and modeling in a neuronal network Cereb Cortex 1 1991 62 79
250. M. Lyvers, and M. Yakimoff Neuropsychological correlates of opioid dependence and withdrawal Addict Behav 28 2003 605 611 (Pubitemid 36287301)
251. J.V. Salgado, L.F. Malloy-Diniz, V.R. Campos, S.S. Abrantes, D. Fuentes, and A. Bechara Neuropsychological assessment of impulsive behavior in abstinent alcohol-dependent subjects Rev Bras Psiquiatr 31 2009 4 9
252. C.A. Winstanley, P. Olausson, J.R. Taylor, and J.D. Jentsch Insight into the relationship between impulsivity and substance abuse from studies using animal models Alcohol Clin Exp Res 34 2010 1306 1318
253. F.R. Levin, J.J. Mariani, A. Secora, D. Brooks, W.Y. Cheng, and A. Bisaga Atomoxetine treatment for cocaine abuse and adult attention-deficit hyperactivity disorder (ADHD): a preliminary open trial J Dual Diagn 5 2009 41 56
254. C.S. Li, P.T. Morgan, D. Matuskey, O. Abdelghany, X. Luo, and J.L. Chang Biological markers of the effects of intravenous methylphenidate on improving inhibitory control in cocaine-dependent patients Proc Natl Acad Sci USA 107 2010 14455 14459
255. D. Economidou, Y. Pelloux, T.W. Robbins, J.W. Dalley, and B.J. Everitt High impulsivity predicts relapse to cocaine-seeking after punishment-induced abstinence Biol Psychiatry 65 2009 851 856
256. M. Sofuoglu Cognitive enhancement as a pharmacotherapy target for stimulant addiction Addiction 105 2010 38 48
257. A. Markou, and G.F. Koob Postcocaine anhedonia. An animal model of cocaine withdrawal Neuropsychopharmacology 4 1991 17 26
258. P.J. Kenny, S.A. Chen, O. Kitamura, A. Markou, and G.F. Koob Conditioned withdrawal drives heroin consumption and decreases reward sensitivity J Neurosci 26 2006 5894 5900 (Pubitemid 44318354)
259. S.H. Ahmed, P.J. Kenny, G.F. Koob, and A. Markou Neurobiological evidence for hedonic allostasis associated with escalating cocaine use Nat Neurosci 5 2002 625 626 (Pubitemid 34742974)
260. N.E. Paterson, and A. Markou Prolonged nicotine dependence associated with extended access to nicotine self-administration in rats Psychopharmacology 173 2004 64 72 (Pubitemid 38591148)
261. L.E. O'Dell, S.A. Chen, R.T. Smith, S.E. Specio, R.L. Balster, and N.E. Paterson Extended access to nicotine self-administration leads to dependence: circadian measures, withdrawal measures, and extinction behavior in rats J Pharmacol Exp Ther 320 2007 180 193 (Pubitemid 46025733)
262. S.A. Chen, L.E. O'Dell, M.E. Hoefer, T.N. Greenwell, E.P. Zorrilla, and G.F. Koob Unlimited access to heroin self-administration: independent motivational markers of opiate dependence Neuropsychopharmacology 31 2006 2692 2707 (Pubitemid 44764166)
263. C.K. Funk, L.E. O'Dell, E.F. Crawford, and G.F. Koob Corticotropin- releasing factor within the central nucleus of the amygdala mediates enhanced ethanol self-administration in withdrawn, ethanol-dependent rats J Neurosci 26 2006 11324 11332 (Pubitemid 44772162)
264. C.D. Gipson, and M.T. Bardo Extended access to amphetamine self-administration increases impulsive choice in a delay discounting task in rats Psychopharmacology 207 2009 391 400
265. N.E. Paterson, and A. Markou Increased motivation for self-administered cocaine after escalated cocaine intake Neuroreport 14 2003 2229 2232
266. L. Orio, S. Edwards, O. George, L.H. Parsons, and G.F. Koob A role for the endocannabinoid system in the increased motivation for cocaine in extended-access conditions J Neurosci 29 2009 4846 4857
267. S. Wee, Z. Wang, W.L. Woolverton, L. Pulvirenti, and G.F. Koob Effect of aripiprazole, a partial dopamine D2 receptor agonist, on increased rate of methamphetamine self-administration in rats with prolonged session duration Neuropsychopharmacology 32 2007 2238 2247 (Pubitemid 47417701)
268. D.M. Hutcheson, B.J. Everitt, T.W. Robbins, and A. Dickinson The role of withdrawal in heroin addiction: enhances reward or promotes avoidance? Nat Neurosci 4 September (9) 2001 943 947 (Pubitemid 32801599)
269. J.L. Rogers, S. De Santis, and R.E. See Extended methamphetamine self-administration enhances reinstatement of drug seeking and impairs novel object recognition in rats Psychopharmacology 199 2008 615 624
270. M. Schwendt, A. Rocha, R.E. See, A.M. Pacchioni, J.F. McGinty, and P.W. Kalivas Extended methamphetamine self-administration in rats results in a selective reduction of dopamine transporter levels in the prefrontal cortex and dorsal striatum not accompanied by marked monoaminergic depletion J Pharmacol Exp Ther 331 2009 555 562
271. J.R. Mantsch, V. Yuferov, A.M. Mathieu-Kia, A. Ho, and M.J. Kreek Effects of extended access to high versus low cocaine doses on self-administration, cocaine-induced reinstatement and brain mRNA levels in rats Psychopharmacology 175 2004 26 36 (Pubitemid 39215527)
272. L.A. Knackstedt, and P.W. Kalivas Extended access to cocaine self-administration enhances drug-primed reinstatement but not behavioral sensitization J Pharmacol Exp Ther 322 2007 1103 1109 (Pubitemid 47295776)
273. J.J. Anker, J.L. Perry, L.A. Gliddon, and M.E. Carroll Impulsivity predicts the escalation of cocaine self-administration in rats Pharmacol Biochem Behav 93 2009 343 348
274. R. McNamara, J.W. Dalley, T.W. Robbins, B.J. Everitt, and D. Belin Trait-like impulsivity does not predict escalation of heroin self-administration in the rat Psychopharmacology 2010 10.1007/s00213-010-1974-9
275. L.J. Vanderschuren, and B.J. Everitt Drug seeking becomes compulsive after prolonged cocaine self-administration Science 305 2004 1017 1019 (Pubitemid 39071779)
276. Y. Pelloux, B.J. Everitt, and A. Dickinson Compulsive drug seeking by rats under punishment: effects of drug taking history Psychopharmacology 194 2007 127 137 (Pubitemid 47282729)
277. D. Belin, E. Balado, P.V. Piazza, and V. Deroche-Gamonet Pattern of intake and drug craving predict the development of cocaine addiction-like behavior in rats Biol Psychiatry 65 2009 863 868
278. F. Kasanetz, V. Deroche-Gamonet, N. Berson, E. Balado, M. Lafourcade, and O. Manzoni Transition to addiction is associated with a persistent impairment in synaptic plasticity Science 328 2010 1709 1712
279. T.N. Greenwell, C.K. Funk, P. Cottone, H.N. Richardson, S.A. Chen, and K.C. Rice Corticotropin-releasing factor-1 receptor antagonists decrease heroin self-administration in long- but not short-access rats Addict Biol 14 2009 130 143
280. S.E. Specio, S. Wee, L.E. O'Dell, B. Boutrel, E.P. Zorrilla, and G.F. Koob CRF(1) receptor antagonists attenuate escalated cocaine self-administration in rats Psychopharmacology 196 2008 473 482 (Pubitemid 351191180)
281. S. Wee, L. Orio, S. Ghirmai, J.R. Cashman, and G.F. Koob Inhibition of kappa opioid receptors attenuated increased cocaine intake in rats with extended access to cocaine Psychopharmacology 205 2009 565 575
282. L. Orio, S. Wee, A.H. Newman, L. Pulvirenti, and G.F. Koob The dopamine D3 receptor partial agonist CJB090 and antagonist PG01037 decrease progressive ratio responding for methamphetamine in rats with extended-access Addict Biol 15 2010 312 323
283. O. George, A. Lloyd, F.I. Carroll, M.I. Damaj, and G.F. Koob Varenicline blocks nicotine intake in rats with extended access to nicotine self-administration Psychopharmacology 2010 10.1007/s00213-010-2024-3
284. R. Gueorguieva, R. Wu, D. Donovan, B.J. Rounsaville, D. Couper, and J.H. Krystal Naltrexone and combined behavioral intervention effects on trajectories of drinking in the COMBINE study Drug Alcohol Depend 107 2010 221 229
285. K. Mann, F. Kiefer, R. Spanagel, and J. Littleton Acamprosate: recent findings and future research directions Alcohol Clin Exp Res 32 2008 1105 1110
286. S. Ross, and E. Peselow The neurobiology of addictive disorders Clin Neuropharmacol 32 2009 269 276
287. A.I. Herman, and M. Sofuoglu Comparison of available treatments for tobacco addiction Curr Psychiatry Rep 12 2010 433 440